Pharmaceutical Care Network Europe

The Pharmaceutical Care Network Europe (PCNE) was established in 1994 by a number of European pharmaceutical care researchers. It became an official association (under Dutch law) in 2004.

Medication Review Drug-related problem classification Guidelines and Indicators

5th PCNE Working Symposium 2016, Hillerød, Denmark

Work in Progress - Progress in Work

19-20 February 2016


IMG 5568The Pharmaceutical Care Network Europe met in Denmark on 19 and 20 February 2016 in Hillerød, Denmark. 

This two-day Symposium with the title ‘Work in Progress - Progress in Work’ was organised to further the work of the PCNE working groups. For this occasion a fourth stream was created with the selection of research outcomes as main topic. The symposium started with an opening lecture by Prof. Dr. Carmel Hughes from Queens University Belfast (N. Ireland) about the structured development of practice research interventions. After the presentation of six short oral communications, the sixty five participants went into four different workshops.

Workshop 1 was dedicated to methods to create guidelines, and participants learned the ins and outs of preparing guidelines with the help of the AGREE tool.

Workshop 2 dealt with Drug-related problems (DRPs). The current version of the DRP classification (V 6.2) needs an update, and the participants discussed what needed to be adapted.

Workshop 3 used a unique consensus method, with electronic voting, to (finally) establish a solid definition of the term ‘Medication Review’. An article on the consensus process will be drafted, and additional considerations will be published on the PCNE website.

Workshop 4 dealt with selecting outcomes of pharmaceutical care studies in a structured manner. For this the concept of a core outcome set (COS) was introduced and discussed, using the COMET website as a lead. The participants proposed to use a future conference to prepare a COS for medication adherence.

See the tab 'Workshops' for the reports

Winner oral award 2016There were almost 50 posters. The poster award was won by S.H Chau from the Vrije Universiteit in Amsterdam, for a poster ‘Cost-effectiveness of gastroprotection with proton pump inhibitors in low-dose acetylsalicylic acid users’. The oral communication award went to Goedele Strauven from the Catholic University Leuven in Belgium. She presented the adaptation of a DRP-classWinner poster award 2016ification for the COME-ON study.

The slides of the oral communications can be found at the 'Program' tab.

 Just like the previous PCNE congresses, this Symposium was very successful. Because the number of participants is relatively small, there is a lot of social interaction, to which a joint wine-tasting and dinner also contributed. See also the picturebook.

The social event including a wine tasting, organised by the honorary member Bente Froekjaer. A brief overview of the wine tasting can be found here.

 

The Conference was financially supported by PharmaDanmark, Springer Nature, the Förderinitiative Pharmazeutische Betreuung and Pharmakon, the Danish College of Pharmacy Practice.

 

Logo FI PharmBetr 2015     Springer      Logo PharmaDanmark 

 

From theory to implementation: attempting to reduce complexity in the development of a complex intervention

Prof. Carmel Hughes, Queens University Belfast, N. Ireland

Find slides of the presentation here

The development of complex interventions in the field of health is recCarmel Hughes 2011eiving increasing attention within the scientific literature. In the past, interventions were often based on the ISLAGIATT principle: that is, ‘It seemed like a good idea at the time’. However, such interventions were frequently ineffective because they were either delivered in part or not at all, demonstrating a lack of fidelity, or because little attention had been paid to their development, content, and mode of delivery. This lecture will outline the latest methodological advances in the field of intervention development, particularly complex interventions. The lecture will draw on health psychology literature, exemplar studies (good and not so good), together with guidance from key organisations and research consortia which are setting standards for development and reporting of these types of intervention studies.

Short bio

Carmel Hughes is Professor of Primary Care Pharmacy and Director of Research (Pharmaceutical Sciences and Practice Cluster) at the School of Pharmacy at Queen’s University Belfast in Northern Ireland. She is also joint Clinical Lead for the Northern Ireland Clinical Research Network for Primary Care. She was the first pharmacist to be awarded a Harkness Fellowship in Primary Care Pharmacy which she spent at Brown University, Providence, Rhode Island. She is the only pharmacist to have received a National Primary Care Career Scientist Award which focused on the interface between pharmacy and general practice. She is the immediate past Chair of the Scientific Advisory Panel for Pharmacy Research UK and is a member of the National Institute of Health Research Health Services and Delivery Research Commissioned Research Panel.

Workshops

  • WS 1: Preparing guidelines for Pharmaceutical Care practice (Martina Teichert and Berry Daemen)

    Click here for a short Workshop report

    Background: Guidelines are the backbone of professional activities – and for today’s pharmacists there should be guidelines on pharmaceutical care. During the workshop the need and format for pharmaceutical care guidelines was discussed, The development and implementation was considered in the light of critical fail and success factors. The different perspectives from different countries helped the participants to share experiences and understand needs and challenges. The workshop was very interactive.

Pharmakon 1

  • Workshop 2 Revising the DRP-classification, making the Version 7.0 (Nejc Horvat and Tommy Westerlund with support of Foppe van Mil)

    Click here for short Workshop Report

    Background: In 1999, the Pharmaceutical Care Network Europe constructed a drug-related problem (DRP) classification system. Since then, the classification system has been validated and adapted regularly. The current version is V6.2.
    The classification is for use in research into the nature, prevalence, and incidence of DRPs and also as a process indicator in experimental studies of Pharmaceutical Care outcomes. It is also meant to help health care professionals to document DRP-information in the pharmaceutical care process.

  • WS 3: Preparing a PCNE standpoint on Medication Review (including issues like medication reconciliation, setting, definition, types and affiliated concepts. (Mitja Kos and Kurt Hersberger)

    Background: PCNE has been actively developing medication review services and research since Portugal meeting in Vimeiro 2009. At that time the aim of medication review was stated as “to optimize outcomes from drug therapy”. This simple definition was discussed at several occasions reaching an additional insight into what medication review services and research are supposed to be. Although several definitions have been already proposed, in Hillerod PCNE reached a final decision on the definition that would suit its members.

  • WS4: Selecting and validating outcome measures on pharmaceutical care interventions. (Carmel Hughes and Linda Thomsen)

    Click here for a short workshop report

    Background: Outcome measures are a critical part of any research project and need careful consideration and selection. Researchers need to assess what outcomes are appropriate for a study, and if suitable and validated measures are available. Furthermore, outcomes which are measured should be meaningful to a range of key stakeholders ranging from patients to policy makers.

Program in a nutshell

Click to download the final version of the program

Program Friday 19 February 2016

8.00-10.00

Registration

10.00-10.15

Opening (Dr. Charlotte Rossing)

10.15-11.00

Plenary lecture: From theory to implementation: attempting to reduce complexity in the development of a complex intervention

Prof. Carmel Hughes, Belfast, N. Ireland

Click for slides of this presentation

11.00-12.30

Oral communications (Chair Dr. Nina Griese)

Barriers and facilitators of implementing a post-discharge community pharmacist home visit.
H.T. Ensing.Utrecht University of Applied Sciences & Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands. 

Click for slides of this presentation

 

Identification of DRPs by pharmaconomists and pharmacists performing two types of medication reviews in a Danish hospital setting.
Trine Nielsen. Region Zealand Hospital Pharmacy, Denmark. 

Click for slides of this presentation

 

How to use dispensing data to measure and signalize nonadherence in diabetes mellitus type 2 patients.
Martina Teichert on behalf of Fong Sodihardjo-Yuen, KNMP, Den Haag, the Netherlands. 

Click for slides of this presentation

 

Drug related problems among ambulatory patients diagnosed with arterial hypertension.
Justyna Dymek, Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University Medical College , Krakow, Poland.

Click for slides of this presentation

 

Deprescribing following medication review in acute care: the ReMAC project.
Thomasz Szymanski, Imperial College London, United Kingdom. 

Click for slides of this presentation

 

The COME-ON study: The development of a Drug-Related Problems classification tool.
Goedele Strauven, Katholieke Universiteit Leuven, Belgie.

Click for slides of this presentation

12.30-13.30

Lunch

13.30-16.30

Workshops 1 and 2

N.B. Maximum number of participants per workshop is 40. -> First come first served <-

 WS 1: Preparing guidelines for Pharmaceutical Care practice. Discussing the need and format for guidelines, and on which topics to start.(Martina Teichert and Berry Daemen, the Netherlands)

WS 2: Revising the DRP-classification. Making the Version 7.0, while including all previous comments(Nejc Horvat, Slovenia, and Tommy Westerlund, Sweden, with extra support of Foppe van Mil)

17.30- 19.30

Poster viewing (and for PCNE members the PCNE Soapbox)

19.30-20.30

Social events

20.30-23.00

PCNE dinner

Program Saturday 20 February 2016

9.00-12.00

Workshops 3 and 4

 N.B. Maximum number of participants per workshop is 40. -> First come first served <-

WS 3: Preparing a PCNE standpoint on Medication Review including the role of medication reconciliation, setting, definition, types and affiliated concepts. (Mitja Kos, Slovenia, and Kurt Hersberger, Switzerland)

WS4: Selecting and validating outcome measures on pharmaceutical care interventions. Discussing the core of pharmaceutical care research. (Carmel Hughes, United Kingdom, and Linda Thomsen, Denmark)

12.00-12.30

Presentation of Workshop results and discussion. 

12.30-13.30

Lunch (Program end for non PCNE members)


Please note: abstract submissions closed 1st December 2015!


 

Abstract submission has closed on the  1st of December 2015. Please find the accepted abstracts below. The slide presentations of the short oral communications can be found on the 'Program' tab.

List of accepted abstracts (click on the title to see the abstract)

ID Title Scope Organization
87 Potentially Inappropriate Medication Related to Weakness in Older Acute Medical Patients Drug-Related Problems Optimized Senior Patient Program (Optimed) at Clinical Research Centre and Emergency department, Hvidovre Hospital, University of Copenhagen, Denmark.
89 Barriers and facilitators of implementing a post-discharge community pharmacist home visit. Drug-Related Problems Utrecht University of Applied Sciences & Utrecht Institute for Pharmaceutical Sciences, Utrecht, the Netherlands
91 The availability of information on impaired renal function in the community pharmacy, a descriptive pilot study Drug-Related Problems PHARMO Database Network
93 Pharmaceutical care issues encountered by people with type 2 diabetes in a hospital setting Drug-Related Problems Pharmacy Department, University Malaya Medical Centre, 59100 Kuala Lumpur, Malaysia
100 How to use dispensing data to measure and signalize nonadherence in diabetes mellitus type 2 patients Drug-Related Problems KNMP
102 Drug related problems among ambulatory patients diagnosed with arterial hypertension Drug-Related Problems Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University Medical College
104 “Safe medication administration in home care” - development of a pharmacy-delivered intervention Drug-Related Problems Pharmakon - Danish College of Pharmacy Practice
105 Implementation of a medication bundle in residential facilities for the disabled - using the Model for Improvement Drug-Related Problems Pharmakon, Danish College of Pharmacy Practice
106 “Safe medication administration in home care” - a pilot test of a pharmacy-delivered intervention Drug-Related Problems Pharmakon - Danish College of Pharmacy Practice
112 Inappropriate prescribing among elderly outpatients in Slovenia in 2013 Drug-Related Problems Chair of Social Pharmacy, Faculty of pharmacy, University of Ljubljana
117 Does type of glucocorticoid containing inhaler device influence asthma outcomes? Drug-Related Problems Chair of Social Pharmacy, University of Ljubljana- Faculty of Pharmacy
124 Are clinicians and pharmacist vigilant about contra-indicated combinations of drugs? Drug-Related Problems GH Pitié Salpêtrière
128 The COME-ON study: The development of a Drug-Related Problems classification tool Drug-Related Problems KU Leuven
90 Medication review in the elderly: how competent are community pharmacists in detecting drug-related problems? Medication Review CiiEM, Instituto Superior de Ciências da Saúde Egas Moniz (ISCSEM), Monte de Caparica, Portugal
92 Barriers and facilitators for the implementation of advanced pharmaceutical services Medication Review CiiEM, Instituto Superior de Ciências da Saúde Egas Moniz (ISCSEM), Monte de Caparica, Portugal
96 Experiences of pharmacists, general practitioners, geriatricians and patients with externally evaluated clinical medication reviews Medication Review Department of General Practice & Elderly Care Medicine, VU University Medical Center, Amsterdam, The Netherlands
97 Whom to serve first with a Medication Review? Medication Review Institute of Pharmacy, Clinical Pharmacy, University of Bonn, Germany
99 Identification of DRPs by pharmaconomists and pharmacists performing two types of medication reviews in a Danish hospital setting. Medication Review Region Zealand Hospital Pharmacy
101 Medication review – what pharmacists can do in Poland Medication Review Department of Social Pharmacy,Jagiellonian University Medical College
110 Deprescribing following medication review in acute care: the ReMAC project Medication Review Imperial College London
113 Introducing Pharmaceutical Care for long-term schizophrenia inpatients Medication Review Farmegra Ltd., Podgorica, Montenegro
126 Pharmacist interventions in pregnant women – comparative study between Serbia and Norway Others (exceptional use) University of Belgrade - Faculty of Pharmacy, Serbia
86 Why should I use my inhaler? – Development and testing of a mHealth intervention for asthma self-management in adolescents Outcomes research UPPER, Utrecht University
94 Cost-effectiveness of gastroprotection with proton pump inhibitors in low-dose acetylsalicylic acid users Outcomes research Department of Clinical Pharmacology and Pharmacy, VU University Medical Center, Amsterdam, the Netherlands
98 The scale of medication errors associated with hospital discharge Outcomes research Pharmakon - Danish College of Pharmacy Practice
114 Association between quality indicator of antibiotic consumption and antimicrobial resistance Outcomes research Faculty of Medicine, Institute of Preventive Medicine and Public Health, University of Lisbon; Centre for Health, Evaluation & Research (CEFAR), National Association of Pharmacies, Lisboa, Portugal
115 MEPAFAC: National School-based Cross-Sectional Study in Spanish adolescents (Abstract 115) Outcomes research Community Pharmacist. Córdoba
116 Enrooting a set of performance indicators for monitoring cognitive pharmacy services in Slovenia Outcomes research Chair of Social Pharmacy, Faculty of Pharmacy, University of Ljubljana, Slovenia
120 Evaluation in community pharmacies of nutritional status among elderly diabetics. Phase 1. Outcomes research SEFAC
121 SEFAC-SEMERGEN “Connects”: Family doctor – Community pharmacy communication programme Outcomes research SEFAC
122 The CESAR programme; Qualification for providing smoking cessation service in community pharmacies. Outcomes research SEFAC
127 Effectiveness of pharmaceutical care in medicated hypertensive patients. AFPRES CLM Study Outcomes research Council of Pharmacists of Castilla-La Mancha, Spain
129 The COME-ON study: Collaborative approach to Optimise MEdication use for Older people in Nursing homes: Process evaluation protocol. Outcomes research Université catholique de Louvain
88 “You can tell by the things they say” - Community pharmacy staff’s perspectives on challenges and solutions for patients with limited health literacy Standards and Guidelines Utrecht University
95 Development of an instrument to assess patient knowledge about therapy with new oral anticoagulants in view of providing targeted education Standards and Guidelines Pharmaceutical Care Research Group
103 Practice-driven restructuring of the pharmacy curricula: focus on advanced services Standards and Guidelines CiiEM, Instituto Superior de Ciências da Saúde Egas Moniz (ISCSEM), Monte de Caparica, Portugal
109 Protocol for consensus-based pharmaceutical indication between the Spanish Society of Family and Community Pharmacy and medical scientific societies Standards and Guidelines Farmacia Barbero
111 SEFAC- Community pharmacy guide on nutritional management in cancer patients Standards and Guidelines Community Pharmacist. Córdoba
119 ImpacHta program: SEFAC and SEH-LELHA training in hypertension and vascular risk, and SEFAC certification of community pharmacists for the provision of hypertension and vascular risk services Standards and Guidelines SEFAC
123 Pharmacies against smoke campaign Standards and Guidelines SEFAC
125 Quick guide to constipation. Frequently asked questions in joint medical-pharmaceutical care Standards and Guidelines SEFAC
130 EDQM Pharmaceutical Care Quality Indicators Project Standards and Guidelines EDQM Quality of Pharmaceutical Care Working Party, Strasbourg, France

Dr. Berry DaemenBerry Daemen

Berry Daemen is a senior projectleader at the Royal Dutch Pharmacist Association, The Hague, the Netherlands. Since 2010 he is responsible of the Dutch guideline program. He is co-author of many Dutch guidelines and standards for pharmaceutical care as well as many clinical multidisciplinary guidelines. His work experience consists of drug development, quality management, implementation projects, practice research and postgraduate education.

 

Prof. Carmel Hughes

Carmel Hughes 2011

Carmel Hughes is Professor of Primary Care Pharmacy and Director of Research (Pharmaceutical Sciences and Practice Cluster) at the School of Pharmacy at Queen’s University Belfast in Northern Ireland. She is also joint Clinical Lead for the Northern Ireland Clinical Research Network for Primary Care. She was the first pharmacist to be awarded a Harkness Fellowship in Primary Care Pharmacy which she spent at Brown University, Providence, Rhode Island. She is the only pharmacist to have received a National Primary Care Career Scientist Award which focused on the interface between pharmacy and general practice. She is the immediate past Chair of the Scientific Advisory Panel for Pharmacy Research UK and is a member of the National Institute of Health Research Health Services and Delivery Research Commissioned Research Panel.

 

Dr. Linda Agaard ThomsenLinda Thomsen

Linda Aaagaard Thomsen is Head of the Department for Research and Development in Community Pharmacy Practice at Pharmakon.
She received her master degree and later her PhD from the School of pharmaceutical Sciences, University of Copenhagen. She received her PhD degree in 2008 with the thesis: ”Quality indicators of preventable adverse drug events in patients with type 2 diabetes”. She was visiting researcher at the University of Florida, Pharmacy Health Care Administration, during her PhD studies. She joined the Pharmakon R&D department in 2008. Her research focuses on patient safety, quality indicators, patient adherence, vulnerable groups, and continuing professional development. Linda Aagaard Thomsen is author and co-author of several research reports and scientific articles, lecturer at national and international congresses as well as member of the advisory board on adverse drug events for the National Agency for Patients' Rights and Complaints.

 

Prof. Mitja KosMitja Kos

Mitja Kos is an associate professor for social pharmacy at the Faculty of Pharmacy, University of Ljubljana, Slovenia and the Head of the Chair of Social Pharmacy. From the beginning of his career he has been developing skills in several different areas including pharmacoepidemiology, pharmacoeconomics, outcomes research, clinical pharmacy and informatics. The focus of his scientific and professional activities are comparative effectiveness and cost-effectiveness of medicines, their safety and pharmacists’ cognitive services. Currently, he is the board member of PCNE and an active member of the commission at the Slovene Chamber of Pharmacies developing medication review services. He is a husband and father of three kids.

 

Dr. Martina TeichertMartina Teichert

Martina Teichert is a scientific advisor at the Royal Dutch Pharmacists Association, The Hague, the Netherlands. There she is responsible for the policy to stimulate pharmaceutical practice research for and by pharmacists. She also works as a senior researcher at the Radboud Medical Centre, Nijmegen, the Netherlands at the department of IQ Healthcare. Her research there addresses the measurement and continuous improvement of pharmaceutical care with additional attention to cost effectiveness.

 

Dr. Nejc Horvat Nejc Horvat

Nejc Horvat is a member of the Chair of Social Pharmacy at University of Ljubljana – Faculty of Pharmacy, Slovenia. He graduated in 2007 with theme titled: “Development of a questionnaire measuring patient satisfaction with pharmacy services”. In 2014, he defended his doctoral thesis titled: “Evaluation of pharmacy services from the patient and expert perspective”. His research focus is primarily the outcomes research, particularly evaluation of pharmacy services and drug related problems.

 

Prof. Tommy Westerlund Tommy Westerlund

Tommy Westerlund is a researcher at the Department of Medicine Use at the Swedish Medical Products Agency (MPA) and an Associate Professor in Social Pharmacy at the Department of Social Medicine, the University of Gothenburg. His research has focused on various topics but most of all on drug-related problems (DRPs) and his PhD thesis was titled “Drug-Related Problems. Identification, Characteristics and Pharmacy Interventions”. He developed a classification of DRPs and interventions, named the Westerlund System, which was used in all Swedish pharmacies during a decade until a year after the re-regulation of the Swedish pharmacy market. Tommy Westerlund has served as the chairman of both the PCNE and the Community Pharmacy Section of the Swedish Academy of Pharmaceutical Sciences. At the MPA, he has primarily been working with Government Commissions from the Swedish Ministry of Health and Social Affairs. 

Picturebook